CereSpir Incorporated is a biotechnology company based out of 41 Madison Ave, New York, New York, United States.
View Top Employees from CereSpir IncorporatedWebsite | http://cerespir.com |
Revenue | $5 million |
Funding | $500000 |
Employees | 3 (1 on RocketReach) |
Founded | 2013 |
Address | 41 Madison Ave Fl 31, New York, New York 10010, US |
Phone | (646) 202-2562 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care, Pharmaceutical |
Competitors | Alector, Cerecin, Compass Therapeutics Inc., Denali Therapeutics, Quince Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular CereSpir Incorporated employee's phone or email?
The CereSpir Incorporated annual revenue was $5 million in 2023.
Adrian Hobden is the CEO of CereSpir Incorporated.
1 people are employed at CereSpir Incorporated.
CereSpir Incorporated is based in New York, New York.
The NAICS codes for CereSpir Incorporated are [54171, 541, 5417, 54, 541714].
The SIC codes for CereSpir Incorporated are [87, 873].